tiprankstipranks
Trending News
More News >
Day One Biopharmaceuticals (DAWN)
NASDAQ:DAWN
US Market

Day One Biopharmaceuticals (DAWN) Income Statement

Compare
398 Followers

Day One Biopharmaceuticals Income Statement

Last quarter (Q3 2025), Day One Biopharmaceuticals's total revenue was $39.80M, a decrease of -57.56% from the same quarter last year. In Q3, Day One Biopharmaceuticals's net income was $-19.73M. See Day One Biopharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 131.16M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 125.88M$ -383.00K$ -531.00K$ -199.00K$ -155.00K
Operating Expenses
$ 343.15M$ 205.68M$ 146.38M$ 72.54M$ 13.63M
Depreciation and Amortization
$ 2.03M$ 383.00K$ 531.00K$ 199.00K$ 155.00K
EBITDA
$ -86.32M$ -188.53M$ -141.65M$ -72.56M$ -43.66M
Operating Income
$ -217.27M$ -206.06M$ -146.91M$ -72.74M$ -13.78M
Other Income/Expenses
$ 128.92M$ 17.15M$ 4.73M$ -11.00K$ -30.06M
Pretax Income
$ -88.35M$ -188.92M$ -142.18M$ -72.75M$ -43.84M
Net Income
$ -95.50M$ -188.92M$ -142.18M$ -70.64M$ -40.51M
Per Share Metrics
Basic EPS
$ -1.02$ -2.37$ -2.02$ -1.14$ -0.65
Diluted EPS
$ -1.02$ -2.37$ -2.02$ -1.14$ -0.65
Weighted Average Shares Outstanding
93.62M 79.77M 65.47M 61.95M 61.93M
Weighted Average Shares Outstanding (Diluted)
93.62M 79.77M 65.47M 61.95M 61.93M
Currency in USD

Day One Biopharmaceuticals Earnings and Revenue History